Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy

British Journal of Radiology

Volumn 71, Issue JULY, 1998, Pages 773-781

  Miura, M ^a   Micca, P L ^a   Fisher, C D ^a   Gordon, C R ^a   Heinrichs, J C ^a   Slatkin, D N ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE; BOROCAPTATE; BORON; COPPER 67; COPPER COMPLEX; HEME; NICKEL COMPLEX; PORPHYRIN; TETRAPHENYLPORPHYRIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; CHEMICAL STRUCTURE; DRUG BLOOD LEVEL; DRUG TARGETING; FEMALE; GLIOBLASTOMA; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

EID: 0031857462     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.71.847.9771389     Document Type: Article

References (16)

1. Coderre JA, Elowitz E, Chadha M, Bergland R, Capala J, Joel DD, et al. Boron neutron capture therapy of glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results. J Neurol Oncol 1997;33:141-52.
2. Miura M, Micca PL, Fisher CD, Heinrichs JC, Donaldson JA, Finkel GC, et al. Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: Biodistribution and toxicity in tumor-bearing mice. Int J Cancer 1996;68:114-9.
3. Oenbrink G, Jürgenlimke P, Gabel D. Accumulation of porphyrins in cells: Influence of hydrophobicity, aggregation and protein binding. Photochem Photobiol 1988;48:451-6.
4. Miura M, Gabel D, Oenbrink G, Fairchild RG. Syntheses of boronated porphyrins for boron neutron capture therapy. Tetrahedron Lett 1990;31:2247-50.
5. Miura M, Micca PL, Heinrichs JC, Gabel D, Fairchild RG. Slatkin DN. Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyl-deuteroporphyrin IX in mice. Biochem Pharmacol 1992;43:467-76.
6. Coderre JA, Button TM, Micca PL, Fisher C, Nawrocky MM, Liu HB. Neutron capture therapy of the 9L gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 1994;30:643-52.
7. Rockwell SC, Kallman RF, Fajardo LF. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture adapted derivative. J Natl Cancer Inst 1972;49:735-47.
8. Slatkin DN. Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyl-deuteroporphyrin IX in mice. Erratum. Biochem Pharmacol 1995;50:893-4.
9. 7Li reaction. Med Phys 1986;13:50-6.
10. Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM, et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity. Radiat Res 1998;149:163-70.
11. 2 administered to mice. Biochem Pharmacol 1986;35:1771-6.
12. Kahl SB, Koo MS, Laster BH, Fairchild RG. Boronated porphyrins in NCT: Results with a new potent tumor localizer. Strahlenther Onkol 1989;165:134-7.
13. Coderre JA, Glass JD, Fairchild RG, Micca PL, Fand I, Joel DD. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma, Cancer Res 1990;50:138-41.
14. Coderre JA, Glass JD, Fairchild RG, Roy U, Cohen S, Fand I. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res 1987;47:6377-83.
15. Morris GM, Coderre JA, Hopewell JW, Micca PL, Rezvani M. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium. Radiother Oncol 1994;32: 144-53.
16. Morris GM, Coderre JA, Hopewell JW, Micca PL, Nawrocky MM, Liu HB, et al. Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord model. Radiother Oncol 1994;32:249-55.